Current vaccine strategies against SARS-CoV-2: Promises and challenges

被引:9
作者
Kurup, Drishya [1 ]
Myers, Jacob [1 ]
Schnell, Matthias J. [1 ,2 ]
机构
[1] Sidney Kimmel Med Coll, Dept Microbiol & Immunol, Philadelphia, PA USA
[2] Thomas Jefferson Univ, Jefferson Vaccine Ctr, Philadelphia, PA 19107 USA
关键词
Approved vaccines; variants of concern; SARS-CoV-2; COVID-19; preclinical vaccines; side effects; vaccine hesitancy; vaccine strategies;
D O I
10.1016/j.jaci.2022.05.008
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
In the years since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic began and spread across the globe, lessons have been learned about the challenges and opportunities that a pandemic brings to humankind. Researchers have produced many vaccines at unprecedented speed to protect people, but they have also been cognizant of the challenges presented by a new and unexpected infectious disease. The scope of this review is to examine the path of vaccine discovery so far and identify potential targets. Here, we provide insight into the leading vaccines and their advantages and challenges. We discuss the emerging mutations within the SARS-CoV-2 spike protein and other issues that need to be addressed to overcome coronavirus disease 2019 (COVID-19) completely. Future research is needed to develop a cheap, temperature-stable vaccine providing long-term immunity that protects the upper respiratory tract.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 43 条
[1]  
Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI [10.1056/NEJMoa2119451, 10.1016/S1473-3099(22)00309-7]
[2]   Current advances in the development of SARS-CoV-2 vaccines [J].
Awadasseid, Annoor ;
Wu, Yanling ;
Tanaka, Yoshimasa ;
Zhang, Wen .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (01) :8-19
[3]   Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination [J].
Beatty, Alexis L. ;
Peyser, Noah D. ;
Butcher, Xochitl E. ;
Cocohoba, Jennifer M. ;
Lin, Feng ;
Olgin, Jeffrey E. ;
Pletcher, Mark J. ;
Marcus, Gregory M. .
JAMA NETWORK OPEN, 2021, 4 (12)
[4]   Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies [J].
Cao, Yunlong ;
Wang, Jing ;
Jian, Fanchong ;
Xiao, Tianhe ;
Song, Weiliang ;
Yisimayi, Ayijiang ;
Huang, Weijin ;
Li, Qianqian ;
Wang, Peng ;
An, Ran ;
Wang, Yao ;
Niu, Xiao ;
Yang, Sijie ;
Liang, Hui ;
Sun, Haiyan ;
Li, Tao ;
Yu, Yuanling ;
Cui, Qianqian ;
Liu, Shuo ;
Yang, Xiaodong ;
Du, Shuo ;
Zhang, Zhiying ;
Hao, Xiaohua ;
Shao, Fei ;
Jin, Ronghua ;
Wang, Xiangxi ;
Xiao, Junyu ;
Wang, Youchun ;
Xie, Xiaoliang Sunney .
NATURE, 2022, 602 (7898) :657-+
[5]   Serological differentiation between COVID-19 and SARS infections [J].
Chia, Wan Ni ;
Tan, Chee Wah ;
Foo, Randy ;
Kang, Adrian Eng Zheng ;
Peng, Yilong ;
Sivalingam, Velraj ;
Tiu, Charles ;
Ong, Xin Mei ;
Zhu, Feng ;
Young, Barnaby E. ;
Chen, Mark I-C ;
Tan, Yee-Joo ;
Lye, David C. ;
Anderson, Danielle E. ;
Wang, Lin-Fa .
EMERGING MICROBES & INFECTIONS, 2020, 9 (01) :1497-1505
[6]  
Chippa V, 2022, POSTACUTE CORONAVIRU
[7]   Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas [J].
Christensen, Paul A. ;
Olsen, Randall J. ;
Long, S. Wesley ;
Snehal, Richard ;
Davis, James J. ;
Saavedra, Matthew Ojeda ;
Reppond, Kristina ;
Shyer, Madison N. ;
Cambric, Jessica ;
Gadd, Ryan ;
Thakur, Rashi M. ;
Batajoo, Akanksha ;
Mangham, Regan ;
Pena, Sindy ;
Trinh, Trina ;
Kinskey, Jacob C. ;
Williams, Guy ;
Olson, Robert ;
Gollihar, Jimmy ;
Musser, James M. .
AMERICAN JOURNAL OF PATHOLOGY, 2022, 192 (04) :642-652
[8]   Antibody titers and breakthrough infections with Omicron SARS-CoV-2 [J].
Dimeglio, Chloe ;
Migueres, Marion ;
Mansuy, Jean-Michel ;
Saivin, Sylvie ;
Miedouge, Marcel ;
Chapuy-Regaud, Sabine ;
Izopet, Jacques .
JOURNAL OF INFECTION, 2022, 84 (04) :E13-E15
[9]   Pan-coronavirus vaccine pipeline takes form [J].
Dolgin, Elie .
NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (05) :324-326
[10]   THE TANGLED HISTORY OF MRNA VACCINES [J].
Dolgin, Elie .
NATURE, 2021, 597 (7876) :318-324